Literature DB >> 24028967

Histopathological and immunohistochemical profile in anaplastic gangliogliomas.

Alfredo E Romero-Rojas1, Julio A Diaz-Perez, Sandra I Chinchilla-Olaya, Deirdre Amaro, Alfonso Lozano-Castillo, Ligia I Restrepo-Escobar.   

Abstract

BACKGROUND: The anaplastic ganglioglioma (AG) is the high-grade counterpart of ganglioglioma, a rare mixed tumor composed of neuronal/ganglion and glial cells.
MATERIALS AND METHODS: We describe the histopathology and immunohistochemistry in 7 cases of AG and correlate them with the clinical and radiological features.
RESULTS: Our AG patients correspond to 2.5% of the central nervous system tumor patients evaluated in our institution. The mean age at presentation was 25.7 years, with a male predominance. The most common clinical presentation was generalized tonic-clonic seizures (3/7 cases), in correlation with frequent cortical/subcortical location (6/7 cases). Histopathologically, all our cases showed high-grade features in glial (glial fibrillary acid protein-positive) and neuron-ganglion cells (synaptophysin, PGP-9.5, neurofilament, NSE and CD56-positive), as well as moderate cellularity, frequent mitotic figures and a Ki-67 labeling index >5%. All our patients had poor survival.
CONCLUSION: We found that a typical histopathological and immunohistochemical profile is constant and can be useful in early diagnosis of these aggressive neoplasms.
Copyright © 2013 Sociedad Española de Neurocirugía. Published by Elsevier España. All rights reserved.

Entities:  

Keywords:  Anaplastic ganglioglioma; Estudio observacional; Ganglioglioma; Ganglioglioma anaplásico; Histopathology; Histopatología; Immunohistochemistry; Inmunohistoquímica; Neurocirugía; Neuroradiology; Neurorradiología; Neurosurgery; Observational study

Mesh:

Year:  2013        PMID: 24028967     DOI: 10.1016/j.neucir.2013.07.001

Source DB:  PubMed          Journal:  Neurocirugia (Astur)        ISSN: 1130-1473            Impact factor:   0.553


  2 in total

1.  Impact of surgery, adjuvant treatment, and other prognostic factors in the management of anaplastic ganglioglioma.

Authors:  Supriya Mallick; Rony Benson; Wineeta Melgandi; Prashanth Giridhar; G K Rath
Journal:  Childs Nerv Syst       Date:  2018-03-29       Impact factor: 1.475

2.  Integrated genotype-phenotype analysis of long-term epilepsy-associated ganglioglioma.

Authors:  Yujiao Wang; Leiming Wang; Ingmar Blümcke; Weiwei Zhang; Yongjuan Fu; Yongzhi Shan; Yueshan Piao; Guoguang Zhao
Journal:  Brain Pathol       Date:  2021-08-05       Impact factor: 6.508

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.